Robert S. Lowrey

Controller, PAO, BioCryst Pharmaceuticals.

Companies

MGT CAPITAL INVESTMENTS, INC.Chief financial officer Mar 9, 2018 to Aug 3, 2018¹
BioCryst PharmaceuticalsController, PAO Feb 28, 2011 to Mar 29, 2012²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMGT CAPITAL INVESTMENTS, INC., Chief financial officer
2
SEC EDGARBioCryst Pharmaceuticals, Controller, PAO